Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-14

Clinical Trial Results: Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of Natrunix in healthy volunteers completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natrunix

Snippet

Sponsor: XBiotech, Inc. | Conditions: Pharmacokinetics | Phase 1 | Status: COMPLETED | Results posted: 2026-08-14